Header background left
Header background right
University Logo

Pharmacy Faculty Publish Q1 Research on Nanoparticle-Based Intranasal Migraine Treatment

By AU Media Team
Published: 28-10-2026
3 min read
Share This:
Preview Image

Dr. Dibyalochan Mohanty, Associate Professor, and Dr. Vasudha Bakshi, Professor and Dean of the School of Pharmacy, have published a research article titled “Development of Smart Thermoresponsive In-Situ Gel Containing Lasmiditan-Loaded Bovine Serum Albumin Nanoparticles for Intranasal Brain Delivery in Migraine Treatment: Optimization, Ex Vivo, In Vivo, and Histopathological Assessment.” The study explores a nanoparticle-based drug delivery approach designed to support intranasal delivery of lasmiditan for migraine treatment.

The research has been published in the Journal of Drug Delivery Science and Technology, by Elsevier. The journal has an Impact Factor of 5.2, is indexed in SCIE and Scopus, has an H-Index of 102, and is classified as Q1. The study incorporates optimization, ex vivo and in vivo investigations, and histopathological assessment to evaluate the proposed formulation.

This publication highlights the faculty members’ contributions to pharmaceutical research, particularly in advanced drug delivery systems and nanoparticle-based formulations. Their work contributes to ongoing academic exploration of innovative approaches to migraine treatment and intranasal drug delivery. The achievement reflects the School of Pharmacy’s continued commitment to research excellence, scientific innovation, and scholarly contributions in pharmaceutical sciences.

AU Logo

Written By

By AU Media Team

This page was last updated on 28-10-2026
Become Team
Designed By
Team BecomeTeam Become

© 2026 Anurag University. All rights reserved.

Anurag University
Pharmacy Faculty Publish Q1 Research on Nanoparticle-Based Intranasal Migraine Treatment | Anurag University